Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 140.28-4.4613.37610.65-249.43

What is the latest EBIT Growth ratio of SOTAC PHARMACEUTICALS ?

The latest EBIT Growth ratio of SOTAC PHARMACEUTICALS is 140.28 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025140.28
Mar2024-4.46
Mar202313.37
Mar2022610.65
Mar2021-249.43

How is EBIT Growth of SOTAC PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 140.28
Positive
Mar2024 -4.46
Negative
Mar2023 13.37
-97.81
Mar2022 610.65
Positive
Mar2021 -249.43 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare EBIT Growth ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹116.6 Cr -5.4% -2.8% -8.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,299.0 Cr 0.5% 1.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹174,207.0 Cr -3.3% -3.5% 1.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹157,721.0 Cr 4.5% 2.6% 42.6% Stock Analytics
CIPLA ₹117,420.0 Cr 2.7% 2.5% -4% Stock Analytics
DR REDDYS LABORATORIES ₹114,876.0 Cr 6.6% 4.3% 1.9% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-5.4%

-2.8%

-8.3%

SENSEX

-0.1%

1%

-5.7%


You may also like the below Video Courses